The design of the Pregnancy Outcomes and Maternal Insulin Sensitivity (PROMIS) study will allow collection of detailed insights in insulin sensitivity and glucose metabolism during (early) pregnancy in women with overweight and obesity and assess its possible relation to growth and body composition during of the offspring during the fetal and early infancy period. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.